Albemarle reported Q1 2026 net sales of $1.43 billion, up 32.7% year over year, with GAAP EPS around $2.71 and adjusted EPS near $3.00, both beating expectations. Shares jumped roughly 7–8% after the release as investors welcomed the sharp rebound in lithium pricing, stronger margins, and raised full year outlook.
About Albemarle Corporation
Albemarle Corporation (NYSE: ALB) is a global specialty chemicals company and one of the world’s largest producers of lithium for electric vehicle batteries and energy storage applications. Founded in 1994 and headquartered in Charlotte, North Carolina, Albemarle also operates significant businesses in bromine specialties and catalysts, though it divested its Ketjen refining catalysts unit in early 2026.
The company’s portfolio serves mobility, energy, connectivity, and health markets, with a heavy strategic emphasis on supplying battery-grade lithium to automotive OEMs and cell manufacturers worldwide. As of early May 2026, Albemarle’s market capitalization is in the mid tens of billions of dollars range, reflecting a recovery from the lithium downcycle of 2024–2025.
The stock trades on a forward P/E in the mid-teens and offers a modest dividend yield around 1%, supported by a long history of dividend payments. Albemarle employs several thousand people globally and continues to invest heavily in resource development and conversion capacity to meet long term EV demand.
Top Financial Highlights
- Q1 2026 net sales were $1,428.7 million, up 32.7% from $1,076.9 million in Q1 2025, driven mainly by higher price and volume in Energy Storage and Specialties.
- Net income attributable to Albemarle Corporation surged to $319.1 million from $41.3 million, an increase of 671.7% year over year.
- Adjusted EBITDA rose to $663.8 million, up 148.5% from $267.1 million in the prior year quarter, reflecting stronger lithium pricing and cost productivity gains.
- GAAP diluted EPS was approximately $2.71, compared with roughly $0.35 a year earlier, while adjusted EPS was around $3.00, far above consensus estimates near $2.25.
- Gross profit increased to $501.0 million from $156.3 million, with gross margin expanding significantly as lithium price realizations improved and productivity initiatives took hold.
- Energy Storage segment net sales grew strongly on higher realized lithium prices and volumes, while Specialties also delivered double digit growth; the Ketjen divestiture reduced net sales growth by roughly 4%.
- Operating income climbed to $233.5 million versus $19.8 million a year ago, even after a $95.0 million loss on sale of the Ketjen business.
- Cash from operating activities was $346 million, and free cash flow reached $248 million after $99 million of capital expenditures.
- Cash and cash equivalents at the beginning of the year were $1.62 billion, providing ample liquidity to fund capex and shareholder returns.
- FY 2026 guidance calls for capital expenditures of $550–$600 million and interest and financing expenses of $120–$140 million, with an adjusted effective tax rate expected between (50)% and 30% reflecting one time items.
- Management reaffirmed or modestly raised its 2026 outlook, citing continued strength in lithium demand and successful execution of cost and productivity programs.
2026 Outlook Considerations
Beat or Miss?
Albemarle’s Q1 2026 results clearly beat Wall Street expectations, with both revenue and EPS coming in above consensus.
| Metric | Reported | Difference/Analysis |
| Revenue (Net sales) | $1.43 billion | Above consensus of about $1.32 billion; roughly a 7–8% beat. |
| GAAP EPS | ~$2.71 | Well above implied expectations around $1.90–$2.00. |
| Adjusted EPS | ~$3.00 | Beat consensus of about $2.25, a positive surprise near 30%. |
| Adjusted EBITDA | $663.8 million | Up 148.5% YoY and ahead of market modeling for a mid $500 million run rate. |
| FY 2026 Outlook | Capex $550–$600 million | Maintained or slightly raised, signaling confidence in demand and returns. |
What Leadership Is Saying?
“Our first quarter results demonstrate the power of Albemarle’s portfolio and the progress we are making on our strategy to be a leading, low cost provider of essential materials for the energy transition. Stronger pricing and volumes in Energy Storage, coupled with improvements in Specialties and disciplined cost management, drove significant year over year growth in sales, earnings and cash flow. With the Ketjen divestiture now complete, we are even more focused on executing our long term growth plans in lithium and bromine while maintaining a strong balance sheet.” – Albemarle President and CEO, from the Q1 2026 results release
“Adjusted EBITDA increased nearly 150% compared to the prior year quarter, supported by higher net sales and ongoing cost and productivity improvements across the business. We generated $346 million in operating cash flow and $248 million in free cash flow in the quarter while investing $99 million in capital expenditures and maintaining our full year capex outlook of $550 to $600 million. These results reinforce our confidence in Albemarle’s ability to fund growth, support our dividend and strengthen our financial position over time.” – Albemarle CFO, commenting on margins, cash flow and capital allocation
Historical Performance
Albemarle delivered a sharp year over year rebound in profitability as lithium prices stabilized and value chain demand improved.
| Category | Q1 2026 | Q1 2025 | Change (%) |
| Revenue (Net sales) | $1,428.7 million | $1,076.9 million | 32.70% |
| Net income attributable | $319.1 million | $41.3 million | 671.70% |
| Adjusted EBITDA | $663.8 million | $267.1 million | 148.50% |
| Operating income | $233.5 million | $19.8 million | Very large increase |
| Operating expenses* | ~$172.4 million (SG&A + R&D) | ~$137.6 million | Higher, with growth and restructuring |
Historical Performance of Competitors
The Q1 2026 release does not provide detailed competitor financials, but Albemarle’s performance can be viewed in the context of global lithium peers such as SQM and Livent/Allkem (Arcadium Lithium) that are also benefiting from recovering prices and volumes.
Public commentary indicates that Albemarle’s 32.7% sales growth and near 150% adjusted EBITDA growth compare favorably with early peer reports, though direct figures for those companies are not included in Albemarle’s materials. As a result, a precise quantitative YoY competitor table cannot be built solely from this announcement and should be supplemented with each peer’s own filings.
How the Market Reacted?
Following the Q1 2026 release, Albemarle’s stock “soared past expectations” coverage noted that revenue and EPS both beat consensus, triggering a strong positive price reaction. Reports indicate that shares rose in the high single digit range, around 7-8%, as investors digested the sharp rebound in net income, margin expansion, and solid free cash flow generation.
The market appears to view the quarter as evidence that Albemarle is emerging from the recent lithium downturn with a leaner cost base and more focused portfolio after the Ketjen divestiture. Sentiment around the stock turned more constructive, with analysts highlighting upside potential if lithium prices remain supportive and the company continues to execute on its capital projects and productivity agenda.
Sources
